TipRanks
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
SPRY
ARS Pharmaceuticals
RESEARCH TOOLSreports
Want to see SPRY full AI Analyst Report?

ARS Pharmaceuticals (SPRY) Balance Sheet

592 Followers

ARS Pharmaceuticals Balance Sheet

ARS Pharmaceuticals's total assets for Q2 2026 were $249.50M, a decrease of -13.24% from the previous quarter. SPRY total liabilities were $236.98M for the fiscal quarter, a 4.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Assets
$ 327.65M$ 351.15M$ 233.19M$ 281.44M$ 61.45M
Total Liabilities
$ 213.39M$ 94.36M$ 2.43M$ 8.55M$ 92.72M
Total Equity Gross Minority
$ 114.26M$ 256.80M$ 230.76M$ 272.89M$ -31.27M
Other Metrics
Currency in USD

ARS Pharmaceuticals Debt to Assets